Skip to content

Zymeworks ZYME Amortization of capitalized software and acquired intangible assets

Amortization of capitalized software and acquired intangible assets at other companies

AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
Charles River Laboratories logo
Charles River LaboratoriesCRL
Innoviva, Inc. logo
Innoviva, Inc.INVA
Adaptive Biotechnologies logo
Adaptive BiotechnologiesADPT
BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX

Other financials

Income statement

See full
Revenue$2.4M-91.1%
Operating income-$47.1M-84.0%
Net income-$44.2M-95.1%
EPS (diluted)-$0.59-96.7%

Balance sheet

See full
Cash & equivalents$244.3M+221%
Total debt$17.0M-7.7%
Total equity$163.6M-49.7%
Total assets$478.2M+12.4%

Cash flow

See full
Operating cash flow-$45.7M-1,242%
CapEx$216.0K+1,250%
Free cash flow-$45.9M-1,242%

Valuation

See full
Market cap$1.76B+125%
Enterprise value$1.53B+112%
P/S21.6×+13.2×

Profitability

See full
Operating margin-140.4%+7.3pp
Net margin-126.3%+5.0pp
FCF margin-94.8%+15.5pp

Returns & leverage

See full
Return on equity-42%+29.2pp
Debt / equity0.1×0.0×
Current ratio10.8×+6.1×

Where this comes from

Reported directly by Zymeworks in its filing.

Tagged under the XBRL concept us-gaap:AmortizationOfIntangibleAssets.

The official record: Zymeworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Zymeworks's amortization of capitalized software and acquired intangible assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Zymeworks's amortization of capitalized software and acquired intangible assets?
Zymeworks (ZYME) reported amortization of capitalized software and acquired intangible assets of $176K in Q1 2026.
How has Zymeworks's amortization of capitalized software and acquired intangible assets changed year-over-year?
Zymeworks's amortization of capitalized software and acquired intangible assets decreased by 89.1% year-over-year, from $1.62M to $176K.
What is the long-term trend for Zymeworks's amortization of capitalized software and acquired intangible assets?
Over 3 years (2022 to 2025), Zymeworks's amortization of capitalized software and acquired intangible assets has grown at a 58.7% compound annual growth rate (CAGR), from $1.02M to $4.06M.